Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 3/2014

01-09-2014 | Original Article

Platelet Storage Media Change the Expression Characteristics of the Platelet-Derived Microparticles

Authors: Fatemeh Yari, Shima Azadpour, Reza Shiri

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 3/2014

Login to get access

Abstract

Activated platelets shed microparticles in vivo and definitely in vitro upon aging under storage. Studies about the platelet-derived microparticles (PMPs) produced in different storage media of PC were very limited. The aim of this research was to compare some surface molecules of these microvesicles in dissimilar microenvironments; plasma and the candidate medium for the platelet concentrate, Composol. Thirty units of PCs were prepared from Iranian Blood Transfusion Organization. Each unit was divided into two portions. In one of the portions, plasma was replaced with Composol using a connecting device instrument. MPs were isolated from PC and the levels of PS exposure (the annexin-binding capacity) and binding to vWF were surveyed on their surface using ELISA and flow cytometry techniques. The levels of PS exposure were increased on MPs during 7 days storage in the both media but the differences were not significant (P value >0.05). In addition, binding of PMP to vWF was declined during storage. The binding capabilities of PMP were significantly higher in Composol than that of plasma at the day 4 or 7 of storage (P value = 001). It seemed that the binding of PMPs to vWF was affected from the storage media of PC (plasma and Composol) but PS exposure was not affected from the type of storage media.
Literature
1.
go back to reference Wolf P (1967) The nature and significance of platelet products in human plasma. Br J Haematol 13:269–288PubMedCrossRef Wolf P (1967) The nature and significance of platelet products in human plasma. Br J Haematol 13:269–288PubMedCrossRef
2.
go back to reference Simak J, Gelderman MP (2006) Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 20(1):1–26PubMedCrossRef Simak J, Gelderman MP (2006) Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 20(1):1–26PubMedCrossRef
3.
go back to reference Horstman LL, Ahn YS (1999) Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol 30(2):111–142PubMedCrossRef Horstman LL, Ahn YS (1999) Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol 30(2):111–142PubMedCrossRef
4.
go back to reference van Engeland M, Ramaekers FC, Schutte B et al (1996) A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 24(2):131–139PubMedCrossRef van Engeland M, Ramaekers FC, Schutte B et al (1996) A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 24(2):131–139PubMedCrossRef
5.
go back to reference Lentz BR (2003) Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Prog Lipid Res 42(5):423–438PubMedCrossRef Lentz BR (2003) Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Prog Lipid Res 42(5):423–438PubMedCrossRef
6.
go back to reference Krishnaswamy S, Church WR, Nesheim ME et al (1987) Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism. J Biol Chem 262(7):3291–3299PubMed Krishnaswamy S, Church WR, Nesheim ME et al (1987) Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism. J Biol Chem 262(7):3291–3299PubMed
7.
go back to reference van Engeland M, Nieland LJ, Ramaekers FC et al (1998) Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31(1):1–9PubMedCrossRef van Engeland M, Nieland LJ, Ramaekers FC et al (1998) Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31(1):1–9PubMedCrossRef
8.
go back to reference Dasgupta SK, Guchhait P, Thiagarajan P (2006) Lactadherin binding and phosphatidylserine expression on cell surface-comparison with annexin A5. Transl Res 148(1):19–25PubMedCrossRef Dasgupta SK, Guchhait P, Thiagarajan P (2006) Lactadherin binding and phosphatidylserine expression on cell surface-comparison with annexin A5. Transl Res 148(1):19–25PubMedCrossRef
9.
go back to reference Mobarrez F, Antovic J, Egberg N et al (2010) A multicolor flow cytometric assay for measurement of platelet-derived microparticles. Thromb Res 125(3):e110–e116PubMedCrossRef Mobarrez F, Antovic J, Egberg N et al (2010) A multicolor flow cytometric assay for measurement of platelet-derived microparticles. Thromb Res 125(3):e110–e116PubMedCrossRef
10.
go back to reference Doggett TA, Girdhar G, Lawshé A et al (2002) Selectin-like kinetics and biomechanics promote rapid platelet adhesion in flow: the GPIb (alpha)–vWF tether bond. Biophys J 83(1):194–205PubMedCentralPubMedCrossRef Doggett TA, Girdhar G, Lawshé A et al (2002) Selectin-like kinetics and biomechanics promote rapid platelet adhesion in flow: the GPIb (alpha)–vWF tether bond. Biophys J 83(1):194–205PubMedCentralPubMedCrossRef
11.
go back to reference Stewart MW, Etches WS, Gordon PA (1988) Analysis of vWF binding to platelets by flow cytometry. Thromb Res 50(3):455–460PubMedCrossRef Stewart MW, Etches WS, Gordon PA (1988) Analysis of vWF binding to platelets by flow cytometry. Thromb Res 50(3):455–460PubMedCrossRef
12.
go back to reference Kang M, Wilson L, Kermode JC (2008) Evidence from limited proteolysis of a ristocetin-induced conformational change in human von Willebrand factor that promotes its binding to platelet glycoprotein Ib–IX–V. Blood Cells Mol Dis 40(3):433–443PubMedCrossRef Kang M, Wilson L, Kermode JC (2008) Evidence from limited proteolysis of a ristocetin-induced conformational change in human von Willebrand factor that promotes its binding to platelet glycoprotein Ib–IX–V. Blood Cells Mol Dis 40(3):433–443PubMedCrossRef
13.
go back to reference Mody NA, King MR (2008) Platelet adhesive dynamics. Part II: High shear-induced transient aggregation via GPIbalpha–vWF–GPIbalpha bridging. Biophys J 95(5):2556–2574PubMedCentralPubMedCrossRef Mody NA, King MR (2008) Platelet adhesive dynamics. Part II: High shear-induced transient aggregation via GPIbalpha–vWF–GPIbalpha bridging. Biophys J 95(5):2556–2574PubMedCentralPubMedCrossRef
14.
go back to reference Van der Meer PF (2007) Platelets additive solutions: a future perspective. Transfus Clin Biol 14(6):522–525PubMedCrossRef Van der Meer PF (2007) Platelets additive solutions: a future perspective. Transfus Clin Biol 14(6):522–525PubMedCrossRef
15.
go back to reference Gyongyossy-Issa MI, Zhang JG, Culibrk B et al (2009) Novel system for storage of buffy-coat-derived platelet concentrates in a glucose-based platelet additive solution: parameters and metabolism during storage and comparison to plasma. Vox Sang 97(2):102–109PubMedCrossRef Gyongyossy-Issa MI, Zhang JG, Culibrk B et al (2009) Novel system for storage of buffy-coat-derived platelet concentrates in a glucose-based platelet additive solution: parameters and metabolism during storage and comparison to plasma. Vox Sang 97(2):102–109PubMedCrossRef
16.
go back to reference Sandgren P, Hansson M, Gulliksson H et al (2007) Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression. Vox Sang 93(1):27–36PubMedCrossRef Sandgren P, Hansson M, Gulliksson H et al (2007) Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression. Vox Sang 93(1):27–36PubMedCrossRef
17.
go back to reference Xiao H, Jepkorir CJ, Harvey K et al (2002) Thrombin induced platelet microparticles improved the aggregability of cryopreserved platelets. Cryobiology 44(2):179–188PubMedCrossRef Xiao H, Jepkorir CJ, Harvey K et al (2002) Thrombin induced platelet microparticles improved the aggregability of cryopreserved platelets. Cryobiology 44(2):179–188PubMedCrossRef
18.
go back to reference Morel O, Toti F, Hugel B et al (2006) Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 26:2594–2604PubMedCrossRef Morel O, Toti F, Hugel B et al (2006) Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 26:2594–2604PubMedCrossRef
19.
go back to reference Sinauridze EI, Kireev DA, Popenko NY et al (2007) Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 97:425–434PubMed Sinauridze EI, Kireev DA, Popenko NY et al (2007) Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 97:425–434PubMed
20.
go back to reference Comfurius P, Smeets EF, Willems GM et al (1994) Assembly of the prothrombinase complex on lipid vesicles depends on the stereochemical configuration of the polar headgroup of phosphatidylserine. Biochemistry 33(34):10319–10324PubMedCrossRef Comfurius P, Smeets EF, Willems GM et al (1994) Assembly of the prothrombinase complex on lipid vesicles depends on the stereochemical configuration of the polar headgroup of phosphatidylserine. Biochemistry 33(34):10319–10324PubMedCrossRef
21.
go back to reference Bevers EM, Comfurius P, Zwaal RF (1983) Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 736(1):57–66PubMedCrossRef Bevers EM, Comfurius P, Zwaal RF (1983) Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 736(1):57–66PubMedCrossRef
22.
go back to reference Lai M, Rumi C, D’Onofrio G et al (2002) Phosphatidylserine exposure in platelet concentrates during the storage period: differences between the platelets collected with different cell separators. Transfus Apher Sci 273:239–245CrossRef Lai M, Rumi C, D’Onofrio G et al (2002) Phosphatidylserine exposure in platelet concentrates during the storage period: differences between the platelets collected with different cell separators. Transfus Apher Sci 273:239–245CrossRef
23.
go back to reference Comfurius P, Senden JM, Tilly RH et al (1990) Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim Biophys Acta 1026:153–160PubMedCrossRef Comfurius P, Senden JM, Tilly RH et al (1990) Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim Biophys Acta 1026:153–160PubMedCrossRef
24.
go back to reference Matijevic N, Wang YW, Kostousov V et al (2011) Decline in platelet microparticles contributes to reduced hemostatic potential of stored plasma. Thromb Res 128(1):35–41PubMedCentralPubMedCrossRef Matijevic N, Wang YW, Kostousov V et al (2011) Decline in platelet microparticles contributes to reduced hemostatic potential of stored plasma. Thromb Res 128(1):35–41PubMedCentralPubMedCrossRef
Metadata
Title
Platelet Storage Media Change the Expression Characteristics of the Platelet-Derived Microparticles
Authors
Fatemeh Yari
Shima Azadpour
Reza Shiri
Publication date
01-09-2014
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 3/2014
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-012-0227-y

Other articles of this Issue 3/2014

Indian Journal of Hematology and Blood Transfusion 3/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine